Overall, these results suggest that PAICS is highly expressed in cancer and can be a marker of breast tumor progression and that four enzymes of the purinosome complex, including PAICS, may determine disease outcomes, particularly in patients with ERα+ breast cancer treated with tamoxifen. The gene discussed is ESR1; the disease is breast carcinoma.